All posts tagged "Biotechnology"

Analysis

Novo Nordisk stocks leap 7% as drugmaker sees copycat Wegovy gross sales easing in 2025

Flags with the emblems of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss...

Analysis

Eli Lilly gross sales jump 45% on weight reduction drug call for, however drugmaker cuts benefit outlook then most cancers remedy do business in

Eli Lilly on Thursday reported first-quarter income and profits that crowned estimates as call for for...

Analysis

CVS tops estimates, hikes steerage as insurance coverage industry displays some development

CVS Pharmacy brand is visible in Washington DC, United States on July 9, 2024. Jakub Porzycki...

Analysis

Pfizer expands charge cuts, tops quarterly benefit estimates at the same time as gross sales fall

The Pfizer emblem is noticeable out of doors the pharmaceutical corporate’s production plant, in Newbridge, Eire...

Analysis

Merck lowers benefit outlook, in part because of $200 million anticipated tariff clash

Nurphoto | Nurphoto | Getty Pictures Merck on Thursday decreased its full-year benefit steerage, bringing up...

Analysis

Bristol Myers Squibb tops quarterly estimates, hikes outlook as drugmaker braces for price lists

FILE PHOTO: The Bristol Myers Squibb analysis and construction middle at Cambridge Crossing in Cambridge, Massachusetts,...

Analysis

Walgreens tops estimates as drugstore chain cuts prices, prepares to advance non-public

An indication for US drugstore chain Walgreens is displayed outdoor its collect in Unused York Town...

Analysis

Moderna beats on income however loses greater than anticipated because it scales ill production

Moderna on Friday posted fourth-quarter revenue that beat estimates, however misplaced greater than anticipated for the...

Analysis

Biogen beats estimates on charge cuts and unused medicine like Leqembi, however benefit outlook falls scale down 

A check tube is discoverable in entrance of displayed Biogen brand on this representation taken on,...

Analysis

CVS stocks pop 10% on weighty income beat, at the same time as top clinical prices drag indisposed insurance coverage unit

CVS Condition on Wednesday reported fourth-quarter income and benefit that crowned estimates, at the same time...